Ultralife CorporationULBINASDAQ
Loading
EBITDA Margin Over TimeContracting
Percentile Rank43
3Y CAGR+17.8%
5Y CAGR-8.6%
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

3Y CAGR
+17.8%/yr
vs -22.1%/yr prior
5Y CAGR
-8.6%/yr
Recent acceleration
Acceleration
+40.0pp
Accelerating
Percentile
P43
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM6.16%-29.6%
20248.75%-7.7%
20239.48%+151.9%
20223.77%+1.9%
20213.69%-61.7%
20209.65%+2.5%
20199.42%-8.0%
201810.24%-1.7%
201710.41%+26.4%
20168.23%-